Nova Leah believe in excellence through knowledge development, sharing and collaboration to enhance the security assurance of medical devices. Nova Leah’s product, SelectEvidence, is an intelligent cybersecurity risk management compliance solution aimed at medical device manufacturers and healthcare providers.

HQ:
Country: Ireland
Establishment
Year:
2015
Company
Stage:
Initial Revenues
Estimated
Employees:
1 .. 10
Estimated
Revenues
$M 1.00
Raised
Funding:
$M 4.90

Tags: